Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Marksans Pharma Limited ( (IN:MARKSANS) ) has issued an update.
Marksans Pharma Limited has strengthened its international footprint by incorporating two new wholly owned subsidiaries: Marksans Pharma (Europe) Limited in Ireland and Marksans (Canada) Inc. in Canada. Both entities, newly formed and without prior turnover, have been set up to conduct pharmaceutical business in their respective regions, signalling a strategic push to deepen Marksans’ presence in key regulated markets and potentially enhance its global distribution, regulatory alignment and market access in Europe and North America.
More about Marksans Pharma Limited
Marksans Pharma Limited is an India-headquartered pharmaceutical company engaged in the development, manufacturing and marketing of pharmaceutical products for global markets. The company focuses on regulated markets such as Europe and North America, supplying a range of generic and specialty medicines across various therapeutic segments.
Average Trading Volume: 55,457
Technical Sentiment Signal: Hold
Current Market Cap: 73.91B INR
For a thorough assessment of MARKSANS stock, go to TipRanks’ Stock Analysis page.